Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
mTOR inhibitor-1
Cat. No.:
OB0225LY-0406
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
mTOR inhibitor-1 is a compound that targets the mTOR pathway and is used to assess the role of this pathway in cellular physiology.
Synonym:
468747-17-3; 3-Bromo-N-[(E)-1-(2,4-dihydroxyphenyl)ethylideneamino]-4-methylbenzamide
CAS No.:
468747-17-3
Compound CID:
136887198
Formula:
C16H15BrN2O3
Formula Weight:
363.21
Specification
Relative Density:
1.48 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
mTOR inhibitor-1 can be used to explore the important role of mTOR in the regulation of cell growth and metabolism.
Library Information
Targets:
PI3K/Akt/mTOR pathway
Receptors:
mTOR
Pathways:
Autophagy; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-6
Plate Location:
c2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
70 mg/mL; 192.72 mM
